In a move that may potentially delay the launch of Dr Reddy’s much anticipated generic Suboxone film, US drug maker Indivior has asserted a new patent to protect the drug going off-patent.Reuters reported on Thursday that the US unit of Indivior has filed patent lawsuits against generic filers such as Dr Reddy’s, Actavis, Par, Alvogen and Teva for infringement of United States patent number 9,855,221.Generic version of Suboxone film, a combination of Buprenorphine and Naloxone used in treatment opioid dependence, is a billion dollar drug for Indivior, a company spun out of British drug major Reckitt Benckiser in 2014.
CapitalStars Award Winning , SEBI registered , ISO certified investment advisory company. We provide intraday & positional services in Equity , derivative ,commodity & currency. Our research is highly skilled & experienced .
Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
No comments:
Post a Comment